Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15,454 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Contemporary Antiplatelet Therapy and Clinical Outcomes of Japanese Patients With Acute Myocardial Infarction　- Results From the Prospective Japan Acute Myocardial Infarction Registry (JAMIR).
Yasuda S, Honda S, Takegami M, Nishihira K, Kojima S, Asaumi Y, Suzuki M, Kosuge M, Takahashi J, Sakata Y, Takayama M, Sumiyoshi T, Ogawa H, Kimura K; JAMIR Investigators. Yasuda S, et al. Among authors: suzuki m. Circ J. 2019 Jul 25;83(8):1633-1643. doi: 10.1253/circj.CJ-19-0145. Epub 2019 Jun 14. Circ J. 2019. PMID: 31204353 Free article.
Rationale, Design, and Baseline Characteristics of the Prospective Japan Acute Myocardial Infarction Registry (JAMIR).
Honda S, Nishihira K, Kojima S, Takegami M, Asaumi Y, Suzuki M, Kosuge M, Takahashi J, Sakata Y, Takayama M, Sumiyoshi T, Ogawa H, Kimura K, Yasuda S; JAMIR investigators. Honda S, et al. Among authors: suzuki m. Cardiovasc Drugs Ther. 2019 Feb;33(1):97-103. doi: 10.1007/s10557-018-6839-1. Cardiovasc Drugs Ther. 2019. PMID: 30470946 Free PMC article.
Characteristics and clinical outcomes of patients with de-escalation from prasugrel to clopidogrel after acute myocardial infarction - Insights from the prospective Japan Acute Myocardial Infarction Registry (JAMIR).
Honda S, Nishihira K, Kojima S, Takegami M, Asaumi Y, Suzuki M, Kosuge M, Takahashi J, Sakata Y, Takayama M, Sumiyoshi T, Ogawa H, Kimura K, Yasuda S; JAMIR Investigators. Honda S, et al. Among authors: suzuki m. J Cardiol. 2021 Aug;78(2):99-106. doi: 10.1016/j.jjcc.2021.03.001. Epub 2021 Mar 19. J Cardiol. 2021. PMID: 33745775 Free article.
Impact of bleeding on mortality in patients with acute myocardial infarction complicated by cardiogenic shock.
Nishihira K, Honda S, Takegami M, Kojima S, Asaumi Y, Suzuki M, Kosuge M, Takahashi J, Sakata Y, Takayama M, Sumiyoshi T, Ogawa H, Kimura K, Yasuda S; JAMIR investigators. Nishihira K, et al. Among authors: suzuki m. Eur Heart J Acute Cardiovasc Care. 2021 May 25;10(4):388-396. doi: 10.1093/ehjacc/zuab014. Eur Heart J Acute Cardiovasc Care. 2021. PMID: 34037718
Effect of Statin Treatment and Low-Density Lipoprotein-Cholesterol on Short-Term Mortality in Acute Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention - Multicenter Registry From Tokyo CCU Network Database.
Miura M, Yamasaki M, Uemura Y, Yoshikawa M, Miyauchi K, Tanaka H, Miyachi H, Yamashita J, Suzuki M, Yamamoto T, Nagao K, Komuro I, Takayama M. Miura M, et al. Among authors: suzuki m. Circ J. 2016;80(2):461-8. doi: 10.1253/circj.CJ-15-0889. Epub 2015 Dec 8. Circ J. 2016. PMID: 26658282 Free article. Clinical Trial.
Rivaroxaban Monotherapy vs Combination Therapy With Antiplatelets on Total Thrombotic and Bleeding Events in Atrial Fibrillation With Stable Coronary Artery Disease: A Post Hoc Secondary Analysis of the AFIRE Trial.
Naito R, Miyauchi K, Yasuda S, Kaikita K, Akao M, Ako J, Matoba T, Nakamura M, Hagiwara N, Kimura K, Hirayama A, Matsui K, Ogawa H; AFIRE Investigators. Naito R, et al. JAMA Cardiol. 2022 Aug 1;7(8):787-794. doi: 10.1001/jamacardio.2022.1561. JAMA Cardiol. 2022. PMID: 35704345 Free PMC article. Clinical Trial.
15,454 results
You have reached the last available page of results. Please see the User Guide for more information.